India makes move to reduce reliance on Chinese APIs

Authorities in Himachal Pradesh have responded to calls to reduce restrictions on bulk drug manufacturers to help relieve India's reliance on Chinese APIs. State authorities approved plans by Lupin Pharmaceuticals and Torrent Pharmaceuticals to set up bulk drug units in a "secluded zone" where companies are overseen by the Investor Promotion Cell and the State Pollution Control Board. The move removes the pharma industry--considered one of the state's 17 most polluting industries--from its "negative list" that discouraged investments, The Tribune reports. Story

Suggested Articles

McCallum was hit with a warning letter from the FDA for testing issues with its products and failing to keep appropriate records.

The FDA made public a voluntary recall of sterile injectables made by Coastal Meds of Mississippi, after visible particles were found in some vials.

It’s been a strange road for BMS' Opdivo-Yervoy combo in first-line kidney cancer, but the New Jersey drugmaker finally has a go-ahead.